Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC-PMP
NCT06513065Phase 3Recruiting
- Sponsor
- University of Southampton
- Start
- Dec 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in pseudomyxoma peritonei (PMP), sponsored by University of Southampton. Started Dec 2024; status: recruiting.
02
Drugs
mitomycin c
03
Conditions
pseudomyxoma peritonei (PMP)
Beyond the preview
Go deeper on NCT06513065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06513065.